-
Report details
-
12
Figures
-
5
Tables
-
Market Analysis: IVD Glucose Testing
-
Overview of IVD Glucose Testing
-
Market Outlook
-
Regional Market
-
Company Briefs
-
Abbott Diagnostics
-
Dexcom
-
Roche
-
Executive News Briefing
-
Briefs
-
Agilent Reorganizes Business Units
-
Natera Co-Founder Named R&D Leader of the Year
-
QIAGEN Moves QIAstat-Dx to Drive Growth
-
OraSure Receives Funding
-
AmplifiDx Captures Additional Funding
-
52North Closes $6 Million in Funding
-
Financial Highlights: Abbott Laboratories, QIAGEN
-
Abbott Continues Steady Performance in 2024; 9M Sales Increase 3.7%
-
QIAGEN Reports Strong Performance in Q3 2024; Raises Guidance
-
Diagnostic Market Mergers, Acquisitions and Partnership Deals
-
Partnerships and Collaborations
-
Mergers and Acquisitions
-
Industry Watch
-
Industry Watch COVID-19/Flu Update
-
Region Watch
-
Broad-based Company Announcements
-
Announcements
-
Roche Receives FDA Expanded Approval
-
Foundation Medicine Received FDA Companion Diagnostic Approval
-
Deepull Receives FDA Breakthrough Device Designation
-
bioMérieux Snags Clearance for Tropical Fever Panel
-
Roche Receives CE Mark for New Cobas Systems 2.0
-
Agilent Received Certification for Companion Diagnostic
|
In Vitro Diagnostics Business Outlook, Volume 3, Issue 6 - Glucose Testing
20 Dec 2024
In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually.
In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including:
- Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities
- A comprehensive view of the IVD market with test categories covered and company briefs
- M&A activities, selected partnerships & collaborations, partnership deals, and more
- Industry & region watch to help tailor strategies
- Analysis of news and events and reporting on news not easily available
Page Count: 35
Table of Contents
-
Market Analysis: IVD Glucose Testing
-
Overview of IVD Glucose Testing
-
Market Outlook
-
Regional Market
-
Company Briefs
-
Abbott Diagnostics
-
Dexcom
-
Roche
-
Executive News Briefing
-
Briefs
-
Agilent Reorganizes Business Units
-
Natera Co-Founder Named R&D Leader of the Year
-
QIAGEN Moves QIAstat-Dx to Drive Growth
-
OraSure Receives Funding
-
AmplifiDx Captures Additional Funding
-
52North Closes $6 Million in Funding
-
Financial Highlights: Abbott Laboratories, QIAGEN
-
Abbott Continues Steady Performance in 2024; 9M Sales Increase 3.7%
-
QIAGEN Reports Strong Performance in Q3 2024; Raises Guidance
-
Diagnostic Market Mergers, Acquisitions and Partnership Deals
-
Partnerships and Collaborations
-
Mergers and Acquisitions
-
Industry Watch
-
Industry Watch COVID-19/Flu Update
-
Region Watch
-
Broad-based Company Announcements
-
Announcements
-
Roche Receives FDA Expanded Approval
-
Foundation Medicine Received FDA Companion Diagnostic Approval
-
Deepull Receives FDA Breakthrough Device Designation
-
bioMérieux Snags Clearance for Tropical Fever Panel
-
Roche Receives CE Mark for New Cobas Systems 2.0
-
Agilent Received Certification for Companion Diagnostic
|
More information about this product
Other Users Also Viewed
30-Country IVD Market Atlas, 2024 (In Vitro Diagnostic Markets for US, China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, Turkey and 20 Other Countries) [December 2024 update]
23 Dec 2024
Now in its fourth and final update in 2024!
What’s Included
One Report Covering 30 Countries
Sizing for 20 Important IVD Market Segments
Segments Estimated for Each Country
Forecasts to 2028 for Each Segment
Updated Quarterly (4 upda…
|
